Climb Bio, Inc. (CLYM)
10.36
-0.51
(-4.69%)
USD |
NASDAQ |
Nov 13, 16:00
10.36
0.00 (0.00%)
After-Hours: 19:59
Climb Bio Price to Book Value : 2.622 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 2.622 |
| November 12, 2026 | 2.752 |
| November 11, 2026 | 3.101 |
| November 10, 2026 | 2.972 |
| November 09, 2026 | 2.787 |
| November 06, 2026 | 2.605 |
| November 05, 2026 | 2.245 |
| November 04, 2026 | 2.362 |
| November 03, 2026 | 2.468 |
| November 02, 2026 | 2.466 |
| October 30, 2026 | 2.595 |
| October 29, 2026 | 2.615 |
| October 28, 2026 | 2.562 |
| October 27, 2026 | 2.422 |
| October 26, 2026 | 2.230 |
| October 23, 2026 | 2.579 |
| October 22, 2026 | 2.668 |
| October 21, 2026 | 2.752 |
| October 20, 2026 | 2.734 |
| October 19, 2026 | 2.463 |
| October 16, 2026 | 2.486 |
| October 15, 2026 | 2.762 |
| October 14, 2026 | 2.605 |
| October 13, 2026 | 2.610 |
| October 12, 2026 | 2.742 |
| Date | Value |
|---|---|
| October 09, 2026 | 2.784 |
| October 08, 2026 | 2.749 |
| October 07, 2026 | 2.711 |
| October 06, 2026 | 2.704 |
| October 05, 2026 | 2.797 |
| October 02, 2026 | 2.769 |
| October 01, 2026 | 2.802 |
| September 30, 2026 | 2.904 |
| September 29, 2026 | 2.757 |
| September 28, 2026 | 2.815 |
| September 25, 2026 | 2.796 |
| September 24, 2026 | 2.851 |
| September 23, 2026 | 3.002 |
| September 22, 2026 | 3.407 |
| September 21, 2026 | 3.270 |
| September 18, 2026 | 3.369 |
| September 17, 2026 | 3.371 |
| September 16, 2026 | 3.383 |
| September 15, 2026 | 3.335 |
| September 14, 2026 | 3.491 |
| September 11, 2026 | 3.417 |
| September 10, 2026 | 3.585 |
| September 09, 2026 | 3.608 |
| September 08, 2026 | 3.812 |
| September 04, 2026 | 3.721 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Korsana Biosciences, Inc. | 3.681 |
| Cullinan Therapeutics, Inc. | 2.378 |
| Q32 Bio, Inc. | 0.9051 |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -- |
Price to Book Value Related Metrics
| PEG Ratio | -1.360 |
| Price | 10.36 |
| Earnings Yield | -7.92% |
| Market Cap | 598.06M |
| PEGY Ratio | -1.360 |